Mangoceuticals Inc. (NASDAQ:MGRX) shares are surging on Monday. However, there is no news to justify the movement.The momentum could be due to last week’s announcement of a lawsuit seeking damages exceeding 73 million dollars against its former technology partner, Clarity Ventures.Lawsuit DetailsThe lawsuit, filed in Texas state court, alleges that Clarity failed to deliver a fully functional, HIPAA-compliant enterprise resource planning and eCommerce platform, which was crucial for Mangoceuticals’ operatio ...